Financials aXichem AB

Equities

AXIC A

SE0005250719

Specialty Chemicals

Delayed Nasdaq Stockholm 11:23:41 2024-04-29 am EDT 5-day change 1st Jan Change
1.195 SEK 0.00% Intraday chart for aXichem AB -14.03% -70.20%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 271 1,095 1,345 779 406.8 229
Enterprise Value (EV) 1 269 1,099 1,314 767 397.3 241.2
P/E ratio -36.7 x -110 x -106 x -57.6 x -26.6 x -13.3 x
Yield - - - - - -
Capitalization / Revenue - 3,182,980,166 x 3,920,055,933 x 634,904,249 x 93,254,618 x 45,739,676 x
EV / Revenue - 3,193,631,328 x 3,830,239,606 x 625,094,958 x 91,087,264 x 48,178,062 x
EV / EBITDA - -126,276,917 x -118,475,262 x -63,852,107 x -29,418,232 x -19,395,960 x
EV / FCF 33.2 x -154 x -115 x -55.3 x -27 x -14.7 x
FCF Yield 3.01% -0.65% -0.87% -1.81% -3.7% -6.82%
Price to Book 8 x 37.6 x 20 x 14.5 x 7.23 x 5.68 x
Nbr of stocks (in thousands) 14,807 14,999 15,931 15,931 16,536 16,536
Reference price 2 18.30 73.00 84.40 48.90 24.60 13.85
Announcement Date 5/15/18 5/7/19 5/5/20 5/7/21 5/10/22 5/26/23
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - 0.344 0.343 1.227 4.362 5.007
EBITDA - -8.7 -11.09 -12.01 -13.51 -12.44
EBIT 1 -7.18 -9.666 -12.44 -13.51 -15.07 -14.54
Operating Margin - -2,809.88% -3,627.99% -1,101.3% -345.48% -290.49%
Earnings before Tax (EBT) 1 -7.375 -9.927 -12.56 -13.51 -15.06 -17.24
Net income 1 -7.375 -9.927 -12.56 -13.51 -15.09 -17.26
Net margin - -2,885.76% -3,662.1% -1,101.39% -346.01% -344.66%
EPS 2 -0.4981 -0.6658 -0.7928 -0.8483 -0.9240 -1.044
Free Cash Flow 1 8.09 -7.125 -11.4 -13.87 -14.72 -16.46
FCF margin - -2,071.22% -3,324.67% -1,130.34% -337.46% -328.8%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/15/18 5/7/19 5/5/20 5/7/21 5/10/22 5/26/23
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3 2022 Q4
Net sales 1 - 0.263 3.539
EBITDA - - -
EBIT 1 - -4.3 -2.253
Operating Margin - -1,634.98% -63.66%
Earnings before Tax (EBT) - - -
Net income -5.201 - -
Net margin - - -
EPS -0.3100 - -
Dividend per Share - - -
Announcement Date 8/25/22 11/24/22 3/3/23
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - 3.66 - - - 12.2
Net Cash position 1 2.01 - 30.8 12 9.45 -
Leverage (Debt/EBITDA) - -0.4211 x - - - -0.9817 x
Free Cash Flow 1 8.09 -7.13 -11.4 -13.9 -14.7 -16.5
ROE (net income / shareholders' equity) -19.6% -31.5% -26.1% -22.4% -27.5% -35.7%
ROA (Net income/ Total Assets) -10.5% -15.7% -14.5% -13.5% -16.4% -15.1%
Assets 1 70.32 63.26 86.74 99.84 91.76 113.9
Book Value Per Share 2 2.290 1.940 4.220 3.370 3.400 2.440
Cash Flow per Share 2 0.3900 0.2500 1.930 0.7600 0.5700 0.4000
Capex - 0.09 0.06 0.03 0.02 -
Capex / Sales - 26.74% 18.37% 2.77% 0.37% -
Announcement Date 5/15/18 5/7/19 5/5/20 5/7/21 5/10/22 5/26/23
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise